Skip to main content

Peer Review reports

From: Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring

Original Submission
3 Apr 2024 Submitted Original manuscript
11 May 2024 Reviewed Reviewer Report
2 Jun 2024 Reviewed Reviewer Report
15 Jun 2024 Author responded Author comments - Davide Mangioni
Resubmission - Version 2
15 Jun 2024 Submitted Manuscript version 2
17 Jun 2024 Author responded Author comments - Davide Mangioni
Resubmission - Version 3
17 Jun 2024 Submitted Manuscript version 3
19 Jun 2024 Author responded Author comments - Davide Mangioni
Resubmission - Version 4
19 Jun 2024 Submitted Manuscript version 4
Publishing
20 Jun 2024 Editorially accepted
28 Jun 2024 Article published 10.1186/s12879-024-09541-4

You can find further information about peer review here.

Back to article page